CARLSBAD, Calif.--(BUSINESS WIRE)--Helixis, Inc., developer of nucleic acid analysis tools, announced today that Jay Flatley, CEO of Illumina, Inc., has joined the company’s board of directors. Under Flatley’s leadership Illumina has become the market leader in genotyping and next-generation sequencing systems, and has completed numerous strategic technology acquisitions. Recognizing the company’s record of growth, Forbes magazine recently named Illumina to its 2009 list of “25 Fastest-Growing Technology Companies in the United States.”
